Midazolam 10mg/2ml solution for injection ampoules
10
£5.58
Morphine sulfate 10mg/1ml solution for injection ampoules
10
£5.40
Naftidrofuryl 100mg capsules
84
£10.05
Nicorandil 10mg tablets
60
£7.58
Nicorandil 20mg tablets
60
£14.56
Olanzapine 20mg tablets
28
£4.06
Oxcarbazepine 600mg tablets
50
£29.90
Oxycodone 5mg/5ml oral solution sugar free
250
£8.48
Oxytetracycline 250mg tablets
28
£15.23
Pregabalin 300mg capsules
56
£2.76
Telmisartan 80mg tablets
28
£14.47
Terbinafine 250mg tablets
14
£3.50
* Please note that Carbimazole 5mg tablets 100 has received an increased concessionary price for October 2024; the price rolled over from September 2024 was £1.98.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.
SPPG have issued correspondence on 28 October 2024 in relation to maintaining the supply of medicines to patients.
SUMMARY
There continues to be unprecedented demands on GP practices and Community Pharmacy services with regards to prescription management.
In order to optimise prescribing and minimise supply and waste issues, all primary healthcare professionals are asked to consider options to improve current systems.
Prescribers are asked to ensure that medicines are prescribed and supplied in appropriate quantities. For the majority of patients, SPPG guidance for repeat prescriptions is to ideally maintain quantities at 28 days, and a maximum of 56 days. Certain exceptions such as HRT and oral contraceptive pill will apply.
Prescriptions for care home residents should be maintained at 28 day supply, and it may be necessary on occasion to prescribe quantities greater or less than 28 days’ supply to allow for medication synchronisation.
Prescriptions for patients who are receiving their medication via a monitored dosage system should be for a maximum 28 day supply to minimise waste from mid-cycle changes and for pharmaceutical stability reasons.
Prescriptions for schedule 2, 3 or 4 controlled drugs should be limited to the quantity necessary for up to 30 days of treatment. Please note previous correspondence regarding this.
Temporary residents, patients travelling overseas, and patients who are resident outside of their usual practice area can receive prescription quantities of up to 3 months supply.
Patients travelling abroad for longer than 3 months should only receive a supply sufficient to enable them to get to their destination and organise an alternative supply.
SPPG recommend that in the majority of cases patients are responsible for ordering their own prescriptions, however there may be circumstances where the community pharmacist may be the most suitable person to provide support for patients with ordering their repeat medications e.g. elderly patients, those with serious mental health illness or learning disability who do not have a representative to do this.
ACTION
SPPG have advised community pharmacies to:
Read the SPPG correspondence and share with relevant members of the pharmacy team.
Review and audit current prescription management processes.
Ensure robust processes are in place for supply of outstanding prescription items by informing patients if prescriptions cannot be dispensed in full and provide an owing slip to facilitate collection of the outstanding medication.
Review patient information that is on display and identify opportunities to educate patients on responsible ordering and waste management.
Consider adding this link to animation related to medicines waste.
Ensure prescription ordering processes and waste management processes comply with professional standards and best practice.
Please contact your local primary care office should you have any queries.
Kind regards,
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
CPNI is pleased to confirm that the Pharmacy First Service for Sore Throat Winter 2024/25 is being offered to all community pharmacies across the network.
CPNI welcomes the expansion of the Pharmacy First Service and the evaluation of last year’s pilot sore throat service demonstrates the importance of this clinical service within community pharmacy.
SPPG correspondence issued 28th October 2024 regarding the Pharmacy First Service for Sore Throat Winter 2024/25 can be viewed here.
SUMMARY
Following a successful evaluation of the pilot sore throat service last year, it has been confirmed that funding has been granted for a similar service this winter.
The service will be offered across the pharmacy network from 1st December 2024 for two months initially to patients aged 5 years and over.
Where assessment indicates that antibiotics are necessary, this can be provided by a Pharmacist Independent Prescriber or in line with the SPPG PGDs.
Mandatory training on service provision will be provided by SPPG at a live Echo session at 7.30pm on Tuesday 5th November 2024. Details on how to join this meeting are included within the correspondence.
The training will be recorded and available to view on the Echo Moodle site for those unable to attend the live session.
The fees payable to provide this service are as follows:
A one off service set-up fee of £200 per contractor.
A consultation fee of £32 per consultation (this includes the costs of RADTs and other consumables).
Reimbursement of the cost of medicines on submission of the prescription or pharmacy voucher to BSO.
Those pharmacies wishing to provide this service are to complete the form at the following linkbefore 5pm on 6th November 2024.
Submissions after the deadline will not be accepted.
Further information including contract completion will be provided in the coming days.
ACTION
Contractors are asked to read the correspondence issued by SPPG regarding the Pharmacy First Service for Sore Throat Winter 2024/25 and share with all relevant members of the team.
Those wishing to provide the Pharmacy First Service for Sore Throat are asked to complete the online formbefore 5pm on 6th November 2024.
Training will be provided by SPPG via Echo at 7.30pm on Tuesday 5th November 2024, those wishing to attend this meeting can access the link within the SPPG correspondence.
Please contact your Pharmacy Advisor if you have any queries regarding this letter.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
Community Pharmacists and their teams are invited to the launch of the Royal Pharmaceutical Society (RPS)/ Marie Curie DaffodilQuality Improvement Standards for Community Pharmacy Palliative Care in Northern Ireland.
The standards have been formally endorsed by the Pharmacy Forum NI, supported by CPNI and SPPG, with input from Specialist Palliative Care Pharmacists.
The important role that community pharmacy teams play in improving the care of palliative patients is recognised, and the standards aim to help the whole pharmacy team build on the good care they already provide.
To hear more about the standards, and a clinical update on medicines use in end of life care, a short virtual meeting is being provided on Wednesday 6 November 2024 at 1pm-1.30pm.
Access to the training provided by the RPS lead and NI Specialist Palliative Care Pharmacists, is available via the following link:
This training is open to all community pharmacy staff members who engage with patients with palliative care needs or their carers.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
